• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高危血液系统疾病中性粒细胞减少发热患者血流感染的预测和危险因素分析:一项前瞻性大规模临床研究的事后分析。

Predictive and risk factor analysis for bloodstream infection in high-risk hematological patients with febrile neutropenia: post-hoc analysis from a prospective, large-scale clinical study.

机构信息

Division of Hematology, Department of Hematology, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, 470-1192, Japan.

Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan.

出版信息

Int J Hematol. 2021 Oct;114(4):472-482. doi: 10.1007/s12185-021-03183-x. Epub 2021 Jun 25.

DOI:10.1007/s12185-021-03183-x
PMID:34170481
Abstract

OBJECTIVES

Bloodstream infection (BSI) is a frequent complication observed in patients with febrile neutropenia (FN). BSI risk factors and incidence vary depending on chemotherapy types and prophylactic antimicrobial agents. We clarified these issues by post-hoc analysis of a prospective clinical trial cohort for severe FN in hematological malignancy.

METHODS

We performed an intention-to-treat analysis of 413 high-risk patients and 1272 blood culture sets.

RESULTS

Overall, 356 patients (86.2%) developed FN, and 20.8% had BSI complications. Prophylactic antimicrobials did not prevent complications of FN and BSI, but the incidence of BSIs of Gram-negative (GN) bacteria was lower than in the non-prophylaxis group (23.8% vs. 56.7%). Multinational Association of Supportive Care in Cancer (MASCC) scores < 20 were significantly correlated with the incidence of BSI, whereas MASCC scores > 21 were not (41.7% vs. 17.2%). The only significant risk factors were hypotension and dehydration. axillary temperatures were higher in GN-caused BSIs than in Gram-positive-caused BSIs and in patients with negative blood culture results (38.7 °C vs. 38.2 °C vs. 38.0 °C). The higher the fever, the higher the incidence of BSI and GN bacteremia.

CONCLUSIONS

MASCC score and axillary temperature are strong predictors of BSI. Non-administration of prophylactic antimicrobials and GN-caused BSI are correlated.

THE CLINICAL TRIAL REGISTRATION NUMBER

UMIN00010411.

摘要

目的

血流感染(BSI)是发热性中性粒细胞减少症(FN)患者常见的并发症。BSI 的危险因素和发生率因化疗类型和预防性抗菌药物而异。我们通过对血液恶性肿瘤严重 FN 的前瞻性临床试验队列进行事后分析来阐明这些问题。

方法

我们对 413 名高危患者和 1272 份血培养集进行了意向治疗分析。

结果

总体而言,356 名患者(86.2%)发生 FN,20.8%发生 BSI 并发症。预防性抗菌药物不能预防 FN 和 BSI 的并发症,但革兰氏阴性(GN)细菌的 BSI 发生率低于非预防组(23.8%比 56.7%)。多国支持治疗癌症协会(MASCC)评分<20 与 BSI 的发生率显著相关,而 MASCC 评分>21 则没有(41.7%比 17.2%)。唯一显著的危险因素是低血压和脱水。GN 引起的 BSI 患者的腋温高于革兰氏阳性菌引起的 BSI 患者和血培养阴性的患者(38.7°C 比 38.2°C 比 38.0°C)。体温越高,BSI 和 GN 菌血症的发生率越高。

结论

MASCC 评分和腋温是 BSI 的强预测因子。未使用预防性抗菌药物和 GN 引起的 BSI 相关。

临床试验注册号

UMIN00010411。

相似文献

1
Predictive and risk factor analysis for bloodstream infection in high-risk hematological patients with febrile neutropenia: post-hoc analysis from a prospective, large-scale clinical study.高危血液系统疾病中性粒细胞减少发热患者血流感染的预测和危险因素分析:一项前瞻性大规模临床研究的事后分析。
Int J Hematol. 2021 Oct;114(4):472-482. doi: 10.1007/s12185-021-03183-x. Epub 2021 Jun 25.
2
Dissecting bloodstream infections in febrile neutropenic patients with hematological malignancies, a decade-long single center retrospective observational study (2009-2019).剖析血液病恶性肿瘤中性粒细胞减少发热患者血流感染:一项长达十年的单中心回顾性观察研究(2009-2019 年)。
J Infect Public Health. 2024 Jan;17(1):152-162. doi: 10.1016/j.jiph.2023.11.017. Epub 2023 Nov 21.
3
Impact of Prophylactic Levofloxacin on Rates of Bloodstream Infection and Fever in Neutropenic Patients with Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation.预防性左氧氟沙星对接受自体造血干细胞移植的多发性骨髓瘤中性粒细胞减少患者血流感染率和发热的影响。
Biol Blood Marrow Transplant. 2015 Oct;21(10):1808-14. doi: 10.1016/j.bbmt.2015.06.017. Epub 2015 Jul 3.
4
A prediction model for bacteremia and transfer to intensive care in pediatric and adolescent cancer patients with febrile neutropenia.儿童和青少年癌症中性粒细胞减少发热患者菌血症和转入重症监护病房的预测模型。
Sci Rep. 2022 May 6;12(1):7429. doi: 10.1038/s41598-022-11576-z.
5
Bloodstream infections in neutropenic patients with haematological malignancies.血液系统恶性肿瘤中性粒细胞减少患者的血流感染
Infect Dis Health. 2020 Feb;25(1):22-29. doi: 10.1016/j.idh.2019.08.006. Epub 2019 Oct 2.
6
Validation of a Stenotrophomonas maltophilia bloodstream infection prediction score in the hematologic malignancy population.血液恶性肿瘤人群中嗜麦芽窄食单胞菌血流感染预测评分的验证。
Ann Hematol. 2024 May;103(5):1745-1752. doi: 10.1007/s00277-024-05686-z. Epub 2024 Mar 8.
7
Trends in bacterial bloodstream infections and resistance in immuno-compromised patients with febrile neutropenia: a retrospective analysis.免疫功能低下伴发热性中性粒细胞减少症患者血流细菌感染及耐药趋势的回顾性分析。
Eur J Pediatr. 2021 Sep;180(9):2921-2930. doi: 10.1007/s00431-021-04056-5. Epub 2021 Apr 9.
8
Prevalence of bloodstream infection pathogens in hemato-oncological patients and predictors of carbapenem-resistant gram-negative bacterial infections during febrile neutropenia.血液感染病原体在血液肿瘤患者中的流行情况以及发热性中性粒细胞减少症期间耐碳青霉烯类革兰氏阴性菌感染的预测因子。
Braz J Infect Dis. 2023 Mar-Apr;27(2):102758. doi: 10.1016/j.bjid.2023.102758. Epub 2023 Feb 18.
9
Fluoroquinolone prophylaxis reduces febrile neutropenia, bloodstream infections from mucosal translocations, and intensive care admissions in high risk hematological patients, a single center experience.
Leuk Lymphoma. 2019 Feb;60(2):488-492. doi: 10.1080/10428194.2018.1488252. Epub 2018 Aug 21.
10
Febrile neutropenia in hematologic malignancies.血液恶性肿瘤患者的中性粒细胞减少伴发热。
Curr Hematol Malig Rep. 2013 Dec;8(4):370-8. doi: 10.1007/s11899-013-0171-4.

引用本文的文献

1
Machine learning-based prognostic model for bloodstream infections in hematological malignancies using Th1/Th2 cytokines.基于机器学习的使用Th1/Th2细胞因子的血液系统恶性肿瘤血流感染预后模型。
BMC Infect Dis. 2025 Mar 26;25(1):415. doi: 10.1186/s12879-025-10808-7.
2
2024 update of the AGIHO guideline on diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients with solid tumours and hematological malignancies.2024年实体肿瘤和血液系统恶性肿瘤成年中性粒细胞减少患者不明原因发热(FUO)诊断和经验性治疗的AGIHO指南更新
Lancet Reg Health Eur. 2025 Jan 31;51:101214. doi: 10.1016/j.lanepe.2025.101214. eCollection 2025 Apr.
3
Microbiology and prognostic prediction model of bloodstream infection in patients with hematological malignancies.
血液病恶性肿瘤患者血流感染的微生物学及预后预测模型。
Front Cell Infect Microbiol. 2023 Jun 30;13:1167638. doi: 10.3389/fcimb.2023.1167638. eCollection 2023.
4
Bloodstream Infections in Patients with Hematologic Diseases: Causative Organisms and Factors Associated with Resistance.血液系统疾病患者的血流感染:致病微生物及与耐药相关的因素
Infect Chemother. 2022 Jun;54(2):340-352. doi: 10.3947/ic.2022.0069.